Impact of Long-Acting Bronchodilators and Exposure to Inhaled Corticosteroids on Mortality in COPD: A Real-Life Retrospective Cohort Study.

The article presents research on the impact of long-acting bronchodilator therapy and associated exposure to inhaled corticosteroids (ICS) on all-cause and cardiovascular mortality in patients with chronic obstructive pulmonary disease (COPD). Treatment of COPD with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) is examined in this retrospective cohort study.